Drugmaker Regeneron Prescribed drugs will purchase genetic testing agency 23andMe Holding for $256 million USD by a chapter public sale, the businesses stated on Monday.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased